{"id":29956,"date":"2017-02-23T12:23:46","date_gmt":"2017-02-23T11:23:46","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=29956"},"modified":"2017-03-07T13:42:46","modified_gmt":"2017-03-07T12:42:46","slug":"efsa-la-resistenza-agli-antimicrobici-resta-alta-afferma-un-rapporto-dellue","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/efsa-la-resistenza-agli-antimicrobici-resta-alta-afferma-un-rapporto-dellue\/","title":{"rendered":"EFSA. Antimicrobial resistance remains high, says EU report"},"content":{"rendered":"

Some bacteria in humans, animals and foods continue to exhibit resistance to widely used antimicrobials, says the latest report on antimicrobial resistance in bacteria (AMR) from the European Food Safety Authority (EFSA) and by the European Center for Disease Prevention and Control (ECDC). The report's findings highlight that AMR poses a serious threat to public and animal health. Infections caused by antimicrobial resistant bacteria cause around 25 000 deaths each year in the EU.<\/strong><\/p>\n

Vytenis Andriukaitis, European Commissioner for Health and Food Safety said: \u201cAntimicrobial resistance is a major concern as it endangers human and animal health. We have made considerable efforts to stop its increase, but this is not enough. We have to be faster, stronger and act on several fronts. This is why the Commission will launch a new action plan this summer which will provide a new framework for coordinating future actions to reduce the spread of AMR."<\/p>\n

The report shows that, in general, multidrug resistance in bacteria of Salmonella<\/em> it is high across the EU. However, experts note that resistance to antimicrobials of primary importance, used in the treatment of severe cases of infection by Salmonella<\/em> in humans, it remains low. Salmonellosis, the disease caused by these bacteria, is the second most commonly reported foodborne disease in the EU.<\/p>\n

Says Mike Catchpole, Scientific Director of ECDC: \u201cEspecially worrying is the fact that some types of Salmonella<\/em> common in humans, such as the Salmonella<\/em>Typhimurium<\/em> monophasic, have a very high multidrug resistance. The cautious use of antibiotics in human and veterinary medicine is extremely important in addressing the challenge posed by antimicrobial resistance. We all have a responsibility to ensure that antibiotics continue to be effective."<\/p>\n

The report also highlights that levels of antimicrobial resistance in Europe continue to vary by geographic region, with countries in northern and western Europe generally having lower levels of resistance than those in southern and eastern Europe. Marta Hugas, Head of EFSA's Biological Hazards and Contaminants Unit, says: \u201cThese geographical variations are probably due to differences in the use of antimicrobials in the EU. For example, countries where actions have been taken to reduce, replace and rethink the use of antimicrobials in animals show lower levels of antimicrobial resistance and a declining trend\u201d.<\/p>\n

This year's publication of the report is accompanied by a data visualization tool, which shows, country by country, data on the levels of resistance of some bacteria found in food, animals and humans.<\/p>\n

<\/a><\/p>\n

Explore the data: Antimicrobial resistance in Europe<\/a><\/p>\n

The report also includes the following findings with possible public health consequences:<\/p>\n